Di Gu
About Di Gu
Di Gu is a Senior Equity Research Analyst at Power Corporation of Canada, specializing in equity value-investment with a focus on the healthcare sector. He has over four years of experience in equity research and has worked with various prestigious firms, including L.e.k. Consulting and McKinsey & Company.
Work at Power Corporation of Canada
Di Gu has served as a Senior Equity Research Analyst at Power Corporation of Canada since 2014. In this role, he focuses on analyzing equity investments, particularly in the healthcare sector. His work involves evaluating Chinese companies listed on stock exchanges in China Mainland, Hong Kong, and the U.S. using a deep value approach. Power Corporation of Canada is a prominent investment holding company based in Canada, which holds a Qualified Foreign Institutional Investor (QFII) license in China.
Education and Expertise
Di Gu holds a Master of Arts in Economics and Finance from Brandeis University, which he completed from 2010 to 2012. He also earned a Bachelor of Arts from Shanghai Jiao Tong University, where he studied Business, Finance, and English from 2006 to 2010. Additionally, he briefly studied English at The Chinese University of Hong Kong in 2007. His educational background provides a strong foundation for his expertise in equity research and analysis.
Background
Di Gu's professional journey includes diverse experiences in equity research and consulting. He began his career with internships at L.e.k. Consulting and McKinsey & Company in 2008. He later worked as an Investment Banking Analyst Intern at Gf Securities in 2009 and as a Business Intelligence Summer Intern at Boston Technologies Inc in 2011. Following his academic pursuits, he joined Novo Nordisk's Global Graduate Program from 2012 to 2014 in Denmark, where he gained leadership experience in a global top pharmaceutical company.
Achievements
Di Gu possesses four years of experience in equity research and two years of leadership experience within the pharmaceutical sector. His analytical skills are complemented by a deep fundamental and value-based approach to equity research, particularly focusing on the healthcare industry. His ability to analyze companies across different stock exchanges highlights his expertise in the field.